Abstract:Objective The aim of the work described here was to investigate the value of dynamic contrast enhanced ultrasound (DCE-US) and quantitative analysis in pre-operative differential diagnosis of intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) in non-cirrhotic liver. Methods In this retrospective study, patients with histopathologically proven ICC and HCC lesions in non-cirrhotic liver were included. All patients underwent contrast-enhanced ultrasound (CEUS) examinations with an Acuson Sequoia unit (Siemens Healthineers, Mountain View, CA, USA) unit or LOGIQ E20 (GE Healthcare, Milwaukee, WI, USA) within 1 wk before surgery. SonoVue (Bracco, Milan, Italy) was used as the contrast agent. B-mode ultrasound (BMUS) features and CEUS enhancement patterns were analyzed. DCE-US analysis was performed by VueBox software (Bracco). Two regions of interest (ROIs) were set in the center of the focal liver lesions and their surrounding liver parenchyma. Time–intensity curves (TICs) were generated, and quantitative perfusion parameters were obtained and compared between the ICC and HCC groups using the Student t -test or Mann–Whitney U -test. Results From November 2020 to February 2022, patients with histopathologically confirmed ICC (n = 30) and HCC (n = 24) lesions in non-cirrhotic liver were included. During the arterial phase (AP) of CEUS, ICC lesions exhibited heterogeneous hyperenhancement (13/30, 43.3%), heterogeneous hypo-enhancement (2/30, 6.7 %) and rim-like hyperenhancement (15/30, 50.0%), whereas all HCC lesions exhibited heterogeneous hyperenhancement (24/24, 100.0%) ( p < 0.05). Subsequently, most of the ICC lesions exhibited AP wash-out (83.3%, 25/30), whereas a few cases exhibited wash-out in the portal venous phase (PVP) (15.7%, 5/30). In contrast, HCC lesions exhibited AP wash-out (41.7%, 10/24), PVP wash-out (41.7%, 10/24) and a small part of late phase wash-out (16.7%, 4/24) ( p < 0.05). Compared with those of HCC lesions, TICs of ICCs revealed earlier and lower enhancement during the AP, faster decline during the PVP and reduced area under the curve. The combined area under the receiver operating characteristic curve (AUROC) of all significant parameters was 0.946, with 86.7% sensitivity, 95.8% specificity and 90.7% accuracy in differential diagnosis between ICC and HCC lesions in non-cirrhotic liver, which improved the diagnostic efficacy of CEUS (58.3% sensitivity, 90.0% specificity and 75.9% accuracy). Conclusion ICC and HCC lesions in non-cirrhotic liver might exhibit some overlap of CEUS features in diagnosis. DCE-US with quantitative analysis would be helpful in pre-operative differential diagnosis.

Comparison Of Contrast-Enhanced Ultrasound And Contrast-Enhanced Helical Ct In The Diagnosis Of High Echo-Level Small Focal Liver Lesions

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Contrast enhanced ultrasonography vs.contrast enhanced computed tomography for the diagnosis of focal lesions of the pancreas

Clinical Value of Contrast-Enhanced Ultrasound in Diagnosis of Hyperechoic Liver Lesions

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Consistency Analysis of Contrast-Enhanced Ultrasound and Contrast-Enhanced Ct in Diagnosis of Small Hepatocellular Carcinoma

The Role of Contrast-Enhanced Ultrasound on the Diagnosis of Small Hepatocellular Carcinoma (≤3cm) in Patients with Cirrhosis

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.

Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography.

Clinical Value of Contrast-Enhanced Ultrasonography in the Characterization of Focal Liver Lesions: a Prospective Multicenter Trial.

Clinical application of contrast-enhanced ultrasonography for malignant hepatic lesions undetected on conventional ultrasound

Comparison of Enhancement Features of Hepatic Tumors Between Dynamic Three-Dimensional and Two-Dimensional Contrast-Enhanced Ultrasonography

Comparison of Contrast‐enhanced Ultrasonography with Virtual Touch Tissue Quantification in the Evaluation of Focal Liver Lesions

[Early Diagnosis of Small Hepatocellular Carcinoma by New Contrast-Enhanced Ultrasound Technique].

Contrast-enhanced Ultrasound (CEUS) for the Diagnosis of Hypoechoic Hepatic Hemangioma in Clinical Practice.

Clinical value of contrast-enhanced ultrasound versus conventional ultrasound in biopsy of focal liver lesions

A comparative study of contrast enhanced ultrasound and contrast enhanced magnetic resonance imaging for the detection and characterization of hepatic hemangiomas.

Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions.

Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver

Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging

Detection of Hepatic Metastases by Contrast-Enhanced Ultrasound Compared with Conventional Ultrasound and Contrast-Enhanced Computed Tomography